Clinical Trials List
2023-04-10 - 2026-10-31
Phase I
Recruiting5
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Shih-Feng Cho Division of Hematology & Oncology
- 謝子禹 Division of Hematology & Oncology
- Yi-Chang Liu Division of Hematology & Oncology
- Tsung-Jang Yeh Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
- 莊哲明 Division of Hematology & Oncology
- 王閔宏 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chien-Chin Lin Division of Others -
- MING YAO Division of General Internal Medicine
- Chieh-Lung Cheng Division of General Internal Medicine
- Wen-Chien Chou Division of Others -
- Tai-Chung Huang Division of General Internal Medicine
- Chien-Yuan Chen Division of General Internal Medicine
- 田豐銘 Division of General Internal Medicine
- Huai-Hsuan Huang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- - - Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HSUAN JEN SHIH Division of Hematology & Oncology
- 林潔 Division of Nuclear Medicine
- Ming-Chung Kao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Wei-Ching Lin Division of Hematology & Oncology
- 陳珈妤 Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- Tzu-Ting Chen Division of Hematology & Oncology
- 王幸婷 Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- 鄭富銘 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
30 participants
